Tomoki Naoe

30.7k total citations · 4 hit papers
352 papers, 15.9k citations indexed

About

Tomoki Naoe is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Tomoki Naoe has authored 352 papers receiving a total of 15.9k indexed citations (citations by other indexed papers that have themselves been cited), including 211 papers in Hematology, 155 papers in Molecular Biology and 78 papers in Genetics. Recurrent topics in Tomoki Naoe's work include Acute Myeloid Leukemia Research (124 papers), Chronic Myeloid Leukemia Treatments (78 papers) and Acute Lymphoblastic Leukemia research (68 papers). Tomoki Naoe is often cited by papers focused on Acute Myeloid Leukemia Research (124 papers), Chronic Myeloid Leukemia Treatments (78 papers) and Acute Lymphoblastic Leukemia research (68 papers). Tomoki Naoe collaborates with scholars based in Japan, United States and Germany. Tomoki Naoe's co-authors include Yukihiro Akao, Hitoshi Kiyoi, Yoshihito Nakagawa, Hidehiko Saito, Ryuzo Ohno, Hartmut Döhner, Miguel Á. Sanz, Alan K. Burnett, David Grimwade and Elihu H. Estey and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Tomoki Naoe

343 papers receiving 15.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

2009 2.4k citations Hartmut Döhner, Elihu H. Estey et al. Blood profile →
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

1999 620 citations Hitoshi Kiyoi, Tomoki Naoe et al. Blood profile →
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

2008 605 citations Miguel Á. Sanz, David Grimwade et al. Blood profile →
let-7 MicroRNA Functions as a Potential Growth Suppressor in Human Colon Cancer Cells

2006 531 citations Yukihiro Akao, Yoshihito Nakagawa et al. profile →

Peers

Countries citing papers authored by Tomoki Naoe

Since Specialization

Citations

This map shows the geographic impact of Tomoki Naoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoki Naoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoki Naoe more than expected).

Fields of papers citing papers by Tomoki Naoe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoki Naoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoki Naoe. The network helps show where Tomoki Naoe may publish in the future.

Co-authorship network of co-authors of Tomoki Naoe

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoki Naoe. A scholar is included among the top collaborators of Tomoki Naoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoki Naoe. Tomoki Naoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia 2024 ·International Journal of Hematology ·(unknown), Toshihiro Miyamoto, Hee‐Je Kim, Yasushi Hiramatsu, June‐Won Cheong, Takayuki Ikezoe, Tomoki Naoe, Koichi Akashi, Satoshi Morita, (unknown), (unknown), (unknown), Takeshi Kadokura, Jason E. Hill, Shuichi Miyawaki, Stanley C. Gill, Alexandra N. Heinloth, Nahla Hasabou	0
2	Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system 2019 ·International Journal of Hematology ·(unknown), Masahiro Kizaki, Naoto Takahashi, Noriyoshi Iriyama, Shinichiro Okamoto, Takaaki Ono, Noriko Usui, Koiti Inokuchi, Chiaki Nakaseko, Mineo Kurokawa, Masahiko Sumi, Fumihiko Nakamura, Tatsuya Kawaguchi, Ritsuro Suzuki, Kazuhito Yamamoto, Kazunori Ohnishi, Itaru Matsumura, Tomoki Naoe	25
3	Genomic and Clinical Characterization of Adult Ph-Negative B-Cell Acute Lymphoblastic Leukemia 2018 ·Blood ·Takahiko Yasuda, (unknown), Shinya Kojima, Masahito Kawazu, Toshihide Ueno, Shinobu Tsuzuki, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki, Keizo Horibe, Hiroyuki Mano, Tomoki Naoe, Masashi Sanada, Fumihiko Hayakawa	4
4	Analysis of the oligomeric states of nucleophosmin using size exclusion chromatography 2018 ·Scientific Reports ·Gyosuke Sakashita, Hitoshi Kiyoi, Tomoki Naoe, Takeshi Urano	13
5	Combination of Ponatinib with Hedgehog Antagonist Vismodegib for Therapy-Resistant BCR-ABL1–Positive Leukemia 2013 ·Clinical Cancer Research ·Seiichiro Katagiri, Tetsuzo Tauchi, Seiichi Okabe, Yosuke Minami, Shinya Kimura, Taira Maekawa, Tomoki Naoe, Kazuma Ohyashiki	35
6	Functionally Deregulated AML1/RUNX1 Cooperates with BCR-ABL to Induce a Blastic Phase-Like Phenotype of Chronic Myelogenous Leukemia in Mice 2013 ·PLoS ONE ·Kiyoko Yamamoto, Shinobu Tsuzuki, Yosuke Minami, Yukiya Yamamoto, Akihiro Abe, Koichi Ohshima, Masao Seto, Tomoki Naoe	6
7	Determination of ferritin and hemosiderin iron in patients with normal iron stores and iron overload by serum ferritin kinetics. 2012 ·PubMed ·Hiroshi Saito, Akihiro Tomita, Haruhiko Ohashi, Hideaki Maeda, Hisao Hayashi, Tomoki Naoe	16
8	Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group 2011 ·International Journal of Hematology ·Minoru Yoshida, Nobu Akiyama, Hiroyuki Fujita, Katsuhiro Miura, Junichi Miyatake, Hiroshi Handa, Katsuyuki Kito, Masatomo Takahashi, Kazuyuki Shigeno, Yoshinobu Kanda, (unknown), Shigeki Ohtake, Hisashi Sakamaki, Kazunori Ohnishi, Shuichi Miyawaki, Ryuzo Ohno, Tomoki Naoe	26
9	Microvesicle-mediated RNA Molecule Delivery System Using Monocytes/Macrophages 2010 ·Molecular Therapy ·Yukihiro Akao, Akio Iio, Tomohiro Itoh, Shunsuke Noguchi, Yuko Itoh, (unknown), Tomoki Naoe	203
10	Adipose Tissue-Derived Mesenchymal Stem Cells Facilitate Hematopoiesis in Vitro and in Vivo 2010 ·American Journal Of Pathology ·(unknown), Takayuki Nakayama, Takashi Yahata, Yukari Muguruma, Shigeki Saito, Yasuhiko Miyata, Koji Yamamoto, Tomoki Naoe	105
11	Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet breakdown → 2009 ·Blood ·Hartmut Döhner, Elihu H. Estey, Sergio Amadori, Frederick R. Appelbaum, Thomas Büchner, Alan K. Burnett, Hervé Dombret, Pierre Fenaux, David Grimwade, Richard A. Larson, Francesco Lo‐Coco, Tomoki Naoe, Dietger Niederwieser, Gert J. Ossenkoppele, Miguel Á. Sanz, Jorge Sierra, Martin S. Tallman, Bob Löwenberg, Clara D. Bloomfield	2350
12	Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance 2009 ·Blood ·Junji Hiraga, Akihiro Tomita, Takumi Sugimoto, Kazuyuki Shimada, Masafumi Ito, Shigeo Nakamura, Hitoshi Kiyoi, Tomohiro Kinoshita, Tomoki Naoe	194
13	CTL Clones Isolated from an HLA-Cw-Mismatched Bone Marrow Transplant Recipient with Acute Graft-Versus-Host Disease 2009 ·The Journal of Immunology ·Kyoko Sugimoto, Makoto Murata, Seitaro Terakura, Tomoki Naoe	9
14	Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan 2008 ·International Journal of Hematology ·Hiroto Narimatsu, Masaki Iino, (unknown), Toshiya Yokozawa, (unknown), Hitoshi Kiyoi, (unknown), (unknown), Hiroatsu Iida, Motohiro Tsuzuki, Masamitsu Yanada, Tomoki Naoe, Ritsuro Suzuki, Isamu Sugiura	7
15	Novel and orally active 5-(1,3,4-oxadiazol-2-yl)pyrimidine derivatives as selective FLT3 inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Hiroshi Ishida, (unknown), (unknown), (unknown), Yoshinori Yamashita, Jiro Kajita, Eiichi Fuse, Hitoshi Kiyoi, Tomoki Naoe, Shiro Akinaga, Yukimasa Shiotsu, Hitoshi Arai	9
16	MicroRNA-143 and -145 in Colon Cancer 2007 ·DNA and Cell Biology ·Yukihiro Akao, Yoshihito Nakagawa, Tomoki Naoe	180
17	Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor 2006 ·International Journal of Hematology ·Yoshihiro Inamoto, (unknown), Koichi Miyamura, Seitaro Terakura, (unknown), Yachiyo Kuwatsuka, Masahiro Tokunaga, Masanobu Kasai, Makoto Murata, Tomoki Naoe, Yoshihisa Kodera	11
18	Sustained activation of c‐jun‐N‐terminal kinase plays a critical role in arsenic trioxide‐induced cell apoptosis in multiple myeloma cell lines 2006 ·Cancer Science ·(unknown), Kazuhito Yamamoto, Shinsuke Iida, Ryuzo Ueda, Nobuhiko Emi, Tomoki Naoe	33
19	Polymorphisms of p53 Arg72Pro, p73 G4C14-to-A4T14 at Exon 2 and p21 Ser31Arg and the risk of non-Hodgkin's Lymphoma in Japanese 2004 ·Leukemia & lymphoma ·Asahi Hishida, Keitaro Matsuo, Kazuo Tajima, Michinori Ogura, Yoshitoyo Kagami, Hirofumi Taji, Yasuo Morishima, Nobuhiko Emi, Tomoki Naoe, Nobuyuki Hamajima	31
20	Efficacy of Early Administration of G-CSF After Intensive Chemotherapy in Acute Leukemia: A Randomized Controlled Trial 1995 ·(unknown), Hironori Yamada, Nobuhiko Emi, Hidehiko Saito, Akihiro Takeshita, Ryuzo Ohno, Hitoshi Yoshida, Tomoki Naoe, Shinichi Kageyama, Shigeru Shirakawa, Yoshihisa Kodera, N Hirabayashi, Hiroshi Nishiwaki, (unknown), Masami Hirano, (unknown), Masao Tanaka, (unknown), Masakazu Nitta, Yoshihisa Morishita	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact